INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.

Gábor Szabó, Pál Soós, Susanne Mandera, Ulrike Heger, Christa Flechtenmacher, Susanne Bährle, Leila Seres, Attila Cziráki, Andre Gries, Zsuszanna Zsengellér, Christian F. Vahl, Siegfried Hagl, Csaba Szabó

    Research output: Contribution to journalArticlepeer-review

    39 Scopus citations

    Fingerprint Dive into the research topics of 'INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.'. Together they form a unique fingerprint.

    Medicine & Life Sciences